# Contineum Therapeutics, Inc.: Form 8-K, filed Jun 26, 2026

- Company: [Contineum Therapeutics, Inc.](/companies/ctnm.md) (CIK 1855175)
- Form: 8-K
- Filed: 2026-06-26
- Accepted by EDGAR: Jun 26, 2026, 20:48 ET
- Period: 2026-06-26
- Accession: 0001628280-26-045804
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1855175/000162828026045804/ctnm-20260626.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1855175/000162828026045804/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1855175/000162828026045804/ctnm-20260626.htm

Filed Jun 26, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-045804. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.